Valuation: Grand Pharmaceutical Group Limited

Market Cap 1.52TCr 193.96Cr 173.93Cr 160.55Cr 145.62Cr 271.29Cr 18TCr 275.23Cr 1.92TCr 765.4Cr 9.69TCr 727.6Cr 712.38Cr 31TCr P/E 2026 *
8.44x
P/E 2027 * 7.72x
Enterprise Value 1.52TCr 193.96Cr 173.93Cr 160.55Cr 145.62Cr 271.29Cr 18TCr 275.23Cr 1.92TCr 765.4Cr 9.69TCr 727.6Cr 712.38Cr 31TCr EV / Sales 2026 *
1.18x
EV / Sales 2027 * 1.08x
Free-Float
34.99%
Yield 2026 *
4.83%
Yield 2027 * 5.29%
1 day-0.80%
1 week-6.96%
Current month-11.87%
1 month-8.72%
3 months-15.63%
6 months-31.47%
Current year-44.65%
1 week 4.3
Extreme 4.305
4.57
1 month 4.3
Extreme 4.305
4.96
Current year 4.3
Extreme 4.305
8.18
1 year 4.3
Extreme 4.305
8.88
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 66 12/05/2011
Director/Board Member 62 31/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Other

Chief Executive Officer

21,500 0.0006%
22/04/26 Other

Chairman

50,000 0.0014%
21/04/26 Other

Chief Executive Officer

58,500 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%-6.96%-47.33%+5.98% 195.52Cr
+0.50%+1.38%+57.09%+129.96% 1,14300Cr
+0.86%+5.14%+45.00%+86.15% 65TCr
-0.14%+0.42%+25.69%+105.85% 51TCr
-0.05%+2.28%+49.14%+67.74% 38TCr
-0.63%-5.97%+61.93%+37.06% 35TCr
+0.34%+2.15%+25.26%+54.27% 29TCr
-0.45%+1.16%+1.74%+26.08% 26TCr
+0.87%+3.08%+54.69%+72.74% 24TCr
+0.08%+3.67%+35.05%+107.78% 20TCr
Average +0.23%+0.14%+30.83%+69.36% 40.29TCr
Weighted average by Cap. +0.40%+0.70%+43.64%+88.98%

Financials

2026 *2027 *
Net sales 1.29TCr 165Cr 147.96Cr 136.58Cr 123.87Cr 230.78Cr 16TCr 234.14Cr 1.63TCr 651.12Cr 8.24TCr 618.96Cr 606.02Cr 26TCr 1.41TCr 179.77Cr 161.2Cr 148.8Cr 134.96Cr 251.44Cr 17TCr 255.09Cr 1.78TCr 709.4Cr 8.98TCr 674.36Cr 660.26Cr 28TCr
Net income 182.65Cr 23Cr 21Cr 19Cr 17Cr 33Cr 2.22TCr 33Cr 230.27Cr 92Cr 1.16TCr 87Cr 86Cr 3.67TCr 199.1Cr 25Cr 23Cr 21Cr 19Cr 35Cr 2.42TCr 36Cr 251.01Cr 100.16Cr 1.27TCr 95Cr 93Cr 4TCr
Net Debt - -
Projected Income Statement - Annual - Grand Pharmaceutical Group Limited
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
28/26/28 HK$4.345 -0.80% 31,95,210
27/26/27 HK$4.380 -1.13% 38,79,500
26/26/26 HK$4.430 -0.56% 31,82,000
23/26/23 HK$4.455 +1.14% 18,09,000
22/26/22 HK$4.405 -3.72% 56,72,500
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Grand Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.345HKD
Average target price
9.527HKD
Spread / Average Target
+119.26%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Grand Pharmaceutical Group Limited